
Small specialist team of physicians and operator-investors in a pharma–VC joint venture, focused exclusively on personalized medicine, data analytics and clinically validated digital therapeutics, with early DTx proven history. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
- Cheque size
- $2M – $5M
- Industries
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

